# Menomadin Foundation

> Menomadin Foundation is a VC fund backing Health Care and Medical Device. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 7
- Last investment: Mar 2026
- Lead investor: 29%
- Last updated: Aug 2026

Menomadin Foundation is a VC fund focused on Health Care and Medical Device. Menomadin Foundation

## Contacts

5 contacts available for Menomadin Foundation. Shizune tracks 1 team members at Menomadin Foundation. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/menomadin-foundation?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 29% |
| Medical Device | 2 | 29% |
| Machine Learning | 2 | 29% |
| Artificial Intelligence | 2 | 29% |
| AgTech | 1 | 14% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 43% |
| Seed | 1 | 14% |
| Funding Round | 1 | 14% |
| Venture - Series Unknown | 1 | 14% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 3 | 43% |
| United States | 3 | 43% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eliran Keren | CEO impact investment and measurement | 2 | https://shizune.co/investors/profile/eliran-keren |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Voltify | Voltify is a climate tech company that offers decarbonization solutions for the freight rail industry. | $30M | Seed | Mar 31, 2026 |  |
| Momentick | Momentick is making a net-zero future a reality. Our advanced algorithms unlock the power of satellite imagery to measure, monitor and reduce GHG emissions. We deliver the technology industries and regulatory bodies need to autonomously detect & monitor emissions on a global scale.--- Precise Emissions Data --- Advanced algorithms applied tosatellite imagery to deliver the precise data crucial for accurately detecting and monitoring emissions on and offshore on a global scale. --- Advanced Multi-satellite imagery --- Emissions intelligence autonomously derived from a wide range of satellite sources for precise detection, high-frequency monitoring and customized reporting. --- Compliance and Verification --- Emissions performance tracked over time to verify regulatory compliance, inform decision-making and drive green energy projects. | $5M |  | Jan 14, 2025 |  |
| enSights | enSights provides a centralized picture of the status and requirements of your renewable energy assets. Collect, store, and learn from your digital assets in a single, centralized location, leveraging the most advanced real-time monitoring and machine learning algorithms to optimize performance and minimize consumption at scale. | $10M | Series A | Dec 04, 2024 |  |
| SupPlant | SupPlant is a company in the field of “IOT” in agriculture. By changing the basic concept of irrigation methods, the SupPlant's unique technology can save water on global scales and improve productivity and yields. During the past 4 years, SupPlant developed a unique artificial intelligence system that is able to analyze data generated fromcrops through sensors and translate this data into irrigation commands. | $27M | Venture - Series Unknown | Mar 14, 2022 |  |
| SupPlant | SupPlant is a company in the field of “IOT” in agriculture. By changing the basic concept of irrigation methods, the SupPlant's unique technology can save water on global scales and improve productivity and yields. During the past 4 years, SupPlant developed a unique artificial intelligence system that is able to analyze data generated fromcrops through sensors and translate this data into irrigation commands. | $10M | Venture - Series Unknown | Jun 13, 2021 |  |
| EyeControl | EyeControl is a pioneer of medical technology, specializing in innovative communication solutions that address unmet healthcare needs. We implement disruptive AI-technologies that connect people and bridge information barriers, facilitating better medical care and decision-making. Our eye-tracking wearable and smart platforms empowercomprehensive, round-the-clock, bi-directional connectivity between patients with communication difficulties, their families, and medical teams. Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time communication and actionable clinical data for patients with various levels of cognition. Established in 2016 by individuals, who share unique personal connections to Locked-in patients, EyeControl is a privately held, rapidly growing startup. Recognized as spearheads of cutting-edge medical innovation, the company is supported by the European Innovation Council, Israel Innovation Authority, investors and advisors representing various sectors.The EyeControl device is FDA listed, CE marked, ISO certified, AMAR registered, and HIPAA compliant; it is federally reimbursed in Israel, the UK, and the US. Clinical trials validating its efficacy in detecting and mitigating Delirium are underway in Israel and the US. |  | Series A | Aug 12, 2020 |  |
| Biobeat | Biobeat develops a wearable device for continuous, noninvasive, accurate, medical-grade monitoring of vital signs that include blood pressure, oxygen saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body temperature, steps, and sweat. Its wearable device automatically uploads the recorded data to asmartphone-based application and to the cloud, where the application can monitor it remotely. Caretakers can intervene if needed, and users can receive alerts directly from the app. This provides caretakers with an important tool to assist in disease management and optimize clinical outcomes. The Biobeat system also facilitates remote monitoring of patients with a variety of medical issues. Ultimately, this solution allows patients to be treated in their homes. It can monitor stationary patients as well as those who perform outdoor activities. In 2018, Biobeat received FDA 510K clearance (K181006) for its monitoring system and partnered with DRIVe, a division of the Biomedical Advanced Research and Development Authority, to develop a wearable monitoring device that diagnoses the flu and infections before any symptoms appear. In August 2019, Biobeat received 510K FDA clearance for its patch and watch. | $8M | Series A | Mar 01, 2020 |  |

7 of 7 investments shown.

## Co-investors
- [Mivtach Shamir Holdings LTD](https://shizune.co/investors/profile/mivtach-shamir-holdings-ltd) — VC Fund, 2 deals together
- [Smart Agro](https://shizune.co/investors/profile/smart-agro-c8b7) — VC Fund, 2 deals together
- [Aleph](https://shizune.co/investors/profile/aleph-vc) — VC Fund, 1 deal together
- [Benslie Investment Group](https://shizune.co/investors/profile/benslie-international-ltd) — VC Fund, 1 deal together
- [Boresight Capital](https://shizune.co/investors/profile/boresight-capital) — VC Fund, 1 deal together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Agriculture (agtech) Investors in Israel](https://shizune.co/investors/agriculture-agtech-investors-israel)
- [Agriculture (agtech) VC Funds in Israel](https://shizune.co/investors/agriculture-agtech-vc-funds-israel)
- [Oil and Gas VC Funds in Middle East](https://shizune.co/investors/oil-and-gas-vc-funds-middle-east)

## FAQ

### What does Menomadin Foundation invest in?

Menomadin Foundation invests primarily in Health Care, Medical Device and Machine Learning startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Menomadin Foundation?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Menomadin Foundation?

The team at Menomadin Foundation includes Eliran Keren (CEO impact investment and measurement). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co